poisar

Stocks · News reference

Leerink Partners Upgrades enGene to Outperform

Fiscal.ai

Leerink Partners upgraded enGene to Outperform from Market Perform with a $5 price target.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaBenzinga Newsdesk

    enGene Holdings Q3 EPS $(0.47) Misses $(0.43) Estimate

    enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.43) by 9.3 percent. This is a 17.54 percent increase over losses of $(0.57) per share from